These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1737925)

  • 1. A toxic shock syndrome toxin-1 peptide that shows homology to mycobacterial heat shock protein 18 is presented as conventional antigen to T cells by multiple HLA-DR alleles.
    Ramesh N; Spertini F; Scholl P; Geha R
    J Immunol; 1992 Feb; 148(4):1025-30. PubMed ID: 1737925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A toxic shock syndrome toxin-1 peptide that shows homology to amino acids 180-193 of mycobacterial heat shock protein 65 is presented as conventional antigen.
    Ramesh N; Parronchi P; Ahern D; Romagnani S; Geha R
    Immunol Invest; 1994 Nov; 23(6-7):381-91. PubMed ID: 7851957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Karp DR; Teletski CL; Scholl P; Geha R; Long EO
    Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
    Scholl PR; Diez A; Geha RS
    J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DR3-restricted T cells from different HLA-DR3-positive individuals recognize the same peptide (amino acids 2-12) of the mycobacterial 65-kDa heat-shock protein.
    Van Schooten WC; Elferink DG; Van Embden J; Anderson DC; De Vries RR
    Eur J Immunol; 1989 Nov; 19(11):2075-9. PubMed ID: 2480902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
    von Bonin A; Ehrlich S; Malcherek G; Fleischer B
    Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
    Moseley AB; Huston DP
    J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
    Dennig D; O'Reilly RJ
    J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
    Geluk A; Bloemhoff W; De Vries RR; Ottenhoff TH
    Eur J Immunol; 1992 Jan; 22(1):107-13. PubMed ID: 1370411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal toxins bind to different sites on HLA-DR.
    Chintagumpala MM; Mollick JA; Rich RR
    J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
    Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
    Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of mycobacterial HSP65 in association with HLA-DR4 is not sufficient for autoreactivity.
    Mustafa AS
    Nutrition; 1995; 11(5 Suppl):661-4. PubMed ID: 8748246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
    Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
    Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of synthetic peptide restriction by HLA-DR alleles in T cells from human subjects, naturally sensitized by Streptococcus mutans.
    Childerstone A; Altmann D; Haron JA; Wilkinson D; Trowsdale J; Lehner T
    J Immunol; 1991 Mar; 146(5):1463-9. PubMed ID: 1993839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
    Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
    Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
    Norrby-Teglund A; Nepom GT; Kotb M
    Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells.
    Janson AA; Klatser PR; van der Zee R; Cornelisse YE; de Vries RR; Thole JE; Ottenhoff TH
    J Immunol; 1991 Nov; 147(10):3530-7. PubMed ID: 1940353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition.
    McNicholl JM; Whitworth WC; Oftung F; Fu X; Shinnick T; Jensen PE; Simon M; Wohlhueter RM; Karr RW
    J Immunol; 1995 Aug; 155(4):1951-63. PubMed ID: 7636246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.